X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13537) 13537
Publication (797) 797
Book Review (162) 162
Book Chapter (78) 78
Book / eBook (68) 68
Magazine Article (35) 35
Conference Proceeding (9) 9
Dissertation (6) 6
Trade Publication Article (6) 6
Newsletter (4) 4
Newspaper Article (3) 3
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8716) 8716
male (6854) 6854
female (5575) 5575
animals (4349) 4349
index medicus (4241) 4241
injections, intravenous (3746) 3746
infusions, intravenous (3453) 3453
middle aged (3432) 3432
adult (2883) 2883
aged (2549) 2549
pharmacology & pharmacy (1955) 1955
rats (1907) 1907
treatment outcome (1660) 1660
heparin - administration & dosage (1631) 1631
time factors (1556) 1556
cardiac & cardiovascular systems (1444) 1444
heparin (1221) 1221
dose-response relationship, drug (1175) 1175
heparin - therapeutic use (1099) 1099
peripheral vascular disease (1090) 1090
surgery (1049) 1049
pharmacokinetics (966) 966
hematology (944) 944
therapy (931) 931
intravenous administration (875) 875
prospective studies (856) 856
anticoagulants - administration & dosage (850) 850
anticoagulants - therapeutic use (841) 841
thrombolytic therapy (831) 831
analysis (830) 830
administration, oral (818) 818
risk factors (806) 806
rats, sprague-dawley (772) 772
care and treatment (762) 762
medicine, general & internal (747) 747
aged, 80 and over (716) 716
dogs (684) 684
mice (679) 679
myocardial infarction - drug therapy (675) 675
health aspects (654) 654
fibrinolytic agents - therapeutic use (653) 653
adolescent (650) 650
medicine & public health (648) 648
retrospective studies (636) 636
neurosciences (616) 616
molecular-weight heparin (613) 613
thrombosis (608) 608
anticoagulants (599) 599
research (599) 599
drug therapy (592) 592
heparin - pharmacology (575) 575
pregnancy (560) 560
drug administration schedule (549) 549
thrombolysis (548) 548
follow-up studies (547) 547
fibrinolytic agents - administration & dosage (541) 541
anesthesiology (520) 520
heparin - adverse effects (516) 516
drug therapy, combination (510) 510
mortality (508) 508
stroke (501) 501
injections, subcutaneous (498) 498
disease models, animal (489) 489
double-blind method (468) 468
acute myocardial-infarction (461) 461
management (459) 459
child (452) 452
acute disease (448) 448
rabbits (447) 447
ischemia (442) 442
endocrinology & metabolism (441) 441
blood pressure - drug effects (438) 438
clinical neurology (437) 437
trial (437) 437
rats, wistar (434) 434
metabolism (431) 431
pediatrics (428) 428
respiratory system (426) 426
patients (424) 424
blood (422) 422
recurrence (421) 421
physiology (411) 411
electrocardiography (409) 409
prevention (409) 409
article (408) 408
deep-vein thrombosis (405) 405
intravenous unfractionated heparin (402) 402
anticoagulants - adverse effects (401) 401
tissue plasminogen activator - therapeutic use (401) 401
administration, intravenous (398) 398
plasma (395) 395
tissue plasminogen activator - administration & dosage (395) 395
complications (391) 391
area under curve (387) 387
medicine (385) 385
veterinary sciences (385) 385
half-life (383) 383
dosage and administration (381) 381
physiological aspects (377) 377
immunology (371) 371
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (45) 45
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Scarborough Hospital - General (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Providence Healthcare - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Theses (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Withdrawn (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13064) 13064
German (206) 206
French (155) 155
Russian (85) 85
Spanish (56) 56
Japanese (37) 37
Polish (31) 31
Italian (25) 25
Portuguese (11) 11
Chinese (8) 8
Czech (7) 7
Swedish (7) 7
Danish (5) 5
Korean (5) 5
Bulgarian (4) 4
Hungarian (4) 4
Norwegian (4) 4
Turkish (4) 4
Romanian (2) 2
Dutch (1) 1
Finnish (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/1991, Volume 324, Issue 22, pp. 1565 - 1574
Journal Article
Circulation, ISSN 0009-7322, 07/2003, Volume 108, Issue 2, pp. 135 - 142
Background-The combination of a single-bolus fibrinolytic and a low-molecular-weight heparin may facilitate prehospital reperfusion and further improve... 
Myocardial infarction | Reperfusion | Heparin | Fibrinolysis | Hemorrhage | MORTALITY | RETEPLASE | CARDIAC & CARDIOVASCULAR SYSTEMS | TISSUE-PLASMINOGEN ACTIVATOR | myocardial infarction | fibrinolysis | heparin | THERAPY | PERIPHERAL VASCULAR DISEASE | REOCCLUSION | reperfusion | INTERVENTION | hemorrhage | Injections, Intravenous | Humans | Middle Aged | Heparin - therapeutic use | Male | Risk | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Heparin - adverse effects | Enoxaparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Time Factors | Hemorrhage - etiology | Injections, Subcutaneous | Thrombolytic Therapy - methods | Female | Safety | Drug Therapy, Combination | Treatment Outcome | Emergency Medical Services - statistics & numerical data | Myocardial Infarction - drug therapy | Survival Analysis | Aged | Emergency Medical Services - methods | Thrombolytic Therapy - adverse effects | Cohort Studies | Hemorrhage/etiology | Enoxaparin/adverse effects/therapeutic use | Injections; Intravenous | Emergency Medical Services/methods/statistics & numerical data | Myocardial Infarction/drug therapy | Injections; Subcutaneous | Thrombolytic Therapy/adverse effects/methods | Drug Therapy; Combination | Research Support; Non-U.S. Gov't | Heparin/adverse effects/therapeutic use | Tissue Plasminogen Activator/adverse effects/therapeutic use
Journal Article
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 07/1997, Volume 96, Issue 1, pp. 61 - 68
Background Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advantages over unfractionated heparin that make it potentially... 
Myocardial infarction | Angina | Heparin | heparin | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | angina | myocardial infarction | COAGULATION | PERIPHERAL VASCULAR DISEASE | ASPIRIN
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 11/2017, Volume 15, Issue 11, pp. 2099 - 2114
Summary Autoimmune heparin‐induced thrombocytopenia (aHIT) indicates the presence in patients of anti‐platelet factor 4 (PF4)–polyanion antibodies that are... 
platelet factor 4 (PF4) | autoimmunity | platelet‐activating antibodies | heparin‐induced thrombocytopenia | high‐dose intravenous immunoglobulin | high-dose intravenous immunoglobulin | heparin-induced thrombocytopenia | platelet-activating antibodies | FACTOR 4/HEPARIN ANTIBODIES | FONDAPARINUX | WARFARIN THROMBOPROPHYLAXIS | IN-VITRO | CONFORMATIONAL-CHANGES | ORTHOPEDIC-SURGERY | CARDIAC-SURGERY | CROSS-REACTIVITY | PERIPHERAL VASCULAR DISEASE | PLATELET ACTIVATION | HEMATOLOGY | platelet factor4 (PF4) | CLINICAL-PRACTICE | Blood Platelets - immunology | Anticoagulants - administration & dosage | Administration, Oral | Autoantibodies - blood | Humans | Immunologic Factors - administration & dosage | Platelet Factor 4 - immunology | Immunoglobulins, Intravenous - administration & dosage | Anticoagulants - adverse effects | Heparin - adverse effects | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Heparin - immunology | Animals | Anticoagulants - immunology | Blood Coagulation - drug effects | Blood Platelets - metabolism | Partial Thromboplastin Time | Purpura, Thrombocytopenic, Idiopathic - immunology | Purpura, Thrombocytopenic, Idiopathic - chemically induced | Platelet Activation - drug effects | Blood Platelets - drug effects | Autoimmunity - drug effects | Thrombocytopenia | Autoimmunity | Fibrin | Medical examination | Immunoglobulin G | Anticoagulants (Medicine) | Sulfates | Blood | Anticoagulants | Immunoglobulins | Intravenous administration | Immune response | Disseminated intravascular coagulation | Polyphosphates | Catheters | Immunosuppressive agents | Recruitment | Thromboplastin | Platelet factor 4 | Polyanions | Side effects | Fibrinogen | Chondroitin sulfate | Heparin | Sulfate | Platelets | Antigen-antibody complexes
Journal Article